Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

609 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study.
Dragoni G, Innocenti T, Amiot A, Castiglione F, Melotti L, Festa S, Savarino EV, Truyens M, Argyriou K, Noviello D, Molnar T, Bouillon V, Bezzio C, Eder P, Fernandes S, Kagramanova A, Armuzzi A, Oliveira R, Viola A, Ribaldone DG, Drygiannakis I, Viganò C, Calella F, Gravina AG, Pugliese D, Chaparro M, Ellul P, Vieujean S, Milla M, Caprioli F; “TOFA-poSTOP” Study Group. Dragoni G, et al. Among authors: castiglione f. Am J Gastroenterol. 2024 Mar 19. doi: 10.14309/ajg.0000000000002676. Online ahead of print. Am J Gastroenterol. 2024. PMID: 38305302 Free article.
Adalimumab in active ulcerative colitis: a "real-life" observational study.
Italian Group for the Study of Inflammatory Bowel Disease; Armuzzi A, Biancone L, Daperno M, Coli A, Pugliese D, Annese V, Aratari A, Ardizzone S, Balestrieri P, Bossa F, Cappello M, Castiglione F, Cicala M, Danese S, D'Incà R, Dulbecco P, Feliciangeli G, Fries W, Genise S, Gionchetti P, Gozzi S, Kohn A, Lorenzetti R, Milla M, Onali S, Orlando A, Papparella LG, Renna S, Ricci C, Rizzello F, Sostegni R, Guidi L, Papi C. Italian Group for the Study of Inflammatory Bowel Disease, et al. Among authors: castiglione f. Dig Liver Dis. 2013 Sep;45(9):738-43. doi: 10.1016/j.dld.2013.03.018. Epub 2013 May 15. Dig Liver Dis. 2013. PMID: 23683530 Free article.
Corrigendum to "Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease" [Dig. Liver Dis. 48 (2016) 360-370].
Armuzzi A, Gionchetti P, Daperno M, Danese S, Orlando A, Scribano ML, Vecchi M, Rizzello F; GIVI (Gruppo Italiano su Vedolizumab nelle IBD) Group. Armuzzi A, et al. Dig Liver Dis. 2016 Sep;48(9):1103. doi: 10.1016/j.dld.2016.06.015. Dig Liver Dis. 2016. PMID: 27555348 No abstract available.
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Sands BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Colombel JF, Törüner M, Jonaitis L, Abhyankar B, Chen J, Rogers R, Lirio RA, Bornstein JD, Schreiber S; VARSITY Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1215-1226. doi: 10.1056/NEJMoa1905725. N Engl J Med. 2019. PMID: 31553834 Clinical Trial.
Oncological and Functional Outcomes of Penile Shaft Sparing Surgery for Localised Penile Cancer: A Systematic Review.
Fallara G, Basile G, Poterek A, Tozzi M, Pang KH, Çakir OO, Bandini M, Ferro M, Musi G, Satchi M, Territo A, Fankhauser C, Castiglione F; EAU-YAU Penile and Testis Cancer Working Group. Fallara G, et al. Among authors: castiglione f. Eur Urol Focus. 2024 May 14:S2405-4569(24)00068-3. doi: 10.1016/j.euf.2024.05.004. Online ahead of print. Eur Urol Focus. 2024. PMID: 38749879 Review.
Asymptomatic microscopic colitis induced by secukinumab.
Megna M, De Lucia M, Fornaro L, Tommasino N, Castiglione F, Cacciapuoti S, Testa A. Megna M, et al. Among authors: castiglione f. JAAD Case Rep. 2024 Apr 9;48:11-13. doi: 10.1016/j.jdcr.2024.03.017. eCollection 2024 Jun. JAAD Case Rep. 2024. PMID: 38745828 Free PMC article. No abstract available.
609 results